Molecular, Physiological, and Motor Performance Defects in DMSXL Mice Carrying >1,000 CTG Repeats from the Human DM1 Locus

MRI of Tibialis Anterior Skeletal Muscle in Myotonic Dystrophy Type 1

(2014) Chantal Coté et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Muscleblind-like 2-Mediated Alternative Splicing in the Developing Brain and Dysregulation in Myotonic Dystrophy

(2012) Konstantinos Charizanis et al.   NEURON

Myotonic dystrophy, when simple repeats reveal complex pathogenic entities: new findings and future challenges

(2011) G. Sicot et al.   HUMAN MOLECULAR GENETICS

Cellular toxicity of expanded RNA repeats: focus on RNA foci

(2011) Marzena Wojciechowska et al.   HUMAN MOLECULAR GENETICS

Separation of Fast from Slow Anabolism by Site-specific PEGylation of Insulin-like Growth Factor I (IGF-I)

(2011) Friedrich Metzger et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Peripheral Neuropathy Is Linked to a Severe Form of Myotonic Dystrophy in Transgenic Mice

(2011) Petrica-Adrian Panaite et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Differential susceptibility of muscles to myotonia and force impairment in a mouse model of myotonic dystrophy

(2011) Michelle Moyer et al.   MUSCLE & NERVE

Long Tract of Untranslated CAG Repeats Is Deleterious in Transgenic Mice

(2011) Ren-Jun Hsu et al.   PLoS One

Myotonic dystrophy mouse models: towards rational therapy development

(2011) Mário Gomes-Pereira et al.   TRENDS IN MOLECULAR MEDICINE

Alternative splicing dysregulation secondary to skeletal muscle regeneration

(2010) James P. Orengo et al.   ANNALS OF NEUROLOGY

Open-Label Trial of Recombinant Human Insulin-like Growth Factor 1/Recombinant Human Insulin-like Growth Factor Binding Protein 3 in Myotonic Dystrophy Type 1

(2010) Chad R. Heatwole et al.   ARCHIVES OF NEUROLOGY

Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: Roles in skeletal muscle growth and differentiation

(2010) Cunming Duan et al.   GENERAL AND COMPARATIVE ENDOCRINOLOGY

CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1

(2010) Amanda J. Ward et al.   HUMAN MOLECULAR GENETICS

Molecular therapy in myotonic dystrophy: focus on RNA gain-of-function

(2010) S. A. M. Mulders et al.   HUMAN MOLECULAR GENETICS

Progressive skeletal muscle weakness in transgenic mice expressing CTG expansions is associated with the activation of the ubiquitin–proteasome pathway

(2010) Alban Vignaud et al.   NEUROMUSCULAR DISORDERS

Non-ATG-initiated translation directed by microsatellite expansions

(2010) T. Zu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Myotonic Dystrophy Transgenic Mice Exhibit Pathologic Abnormalities in Diaphragm Neuromuscular Junctions and Phrenic Nerves

(2009) Petrica-Adrian Panaite et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Muscleblind-Like Proteins

(2008) Ian Holt et al.   AMERICAN JOURNAL OF PATHOLOGY

Slow myosin heavy chain expression in the absence of muscle activity

(2008) O. Agbulut et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Impaired recovery of dysferlin-null skeletal muscle after contraction-induced injury in vivo

(2008) Joseph A. Roche et al.   NEUROREPORT

The physiological effects of IGF-1 (class 1:Ea transgene) over-expression on exercise-induced damage and adaptation in dystrophic muscles of mdx mice

(2008) James A. Ridgley et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Myotonic dystrophy type I in childhood

(2007) Bernard Echenne et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY